共 47 条
[1]
Langan SM(2020)Atopic dermatitis Lancet 396 345-360
[2]
Irvine AD(2008)Use of topical corticosteroids and topical calcineurin inhibitors for the treatment of atopic dermatitis in thin and sensitive skin areas Curr Med Res Opin 24 985-994
[3]
Weidinger S(1994)Atopic dermatitis with severe facial lesions exacerbated by contact dermatitis from topical medicaments Contact Derm 31 261-263
[4]
Draelos ZD(2015)Diagnosis of atopic dermatitis: mimics, overlaps, and complications J Clin Med 4 884-917
[5]
Tada J(2009)Choosing topical corticosteroids Am Fam Physician 79 135-140
[6]
Toi Y(2020)ETFAD/EADV Eczema task force 2020 position paper on diagnosis and treatment of atopic dermatitis in adults and children J Eur Acad Dermatol Venereol 34 2717-2744
[7]
Arata J(2019)Dual blockade of IL-14 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation Allergy 75 1188-1204
[8]
Siegfried EC(2017)Commonality of the IL-4/IL-13 pathway in atopic diseases Expert Rev Clin Immunol 13 425-437
[9]
Herbert AA(2022)Current and emerging strategies to inhibit type 2 inflammation in atopic dermatitis Dermatol Ther (Heidelb) 12 1501-1533
[10]
Ference JD(2022)Dupilumab in children 6 months to younger than 6 years with uncontrolled atopic dermatitis: a randomised, double-blind, placebo-controlled, phase 3 trial Lancet 400 908-919